Methamphetamine enhances histoplasmosis by immunosuppression of the host

Luis R Martinez1, Mircea Radu Mihu, Attila Gácser

  • 1Division of Infectious Diseases, Department of Medicine, Albert Einstein College of Medicine, Bronx, New York 10461, USA.

Insights

Methamphetamine impairs macrophage function, hindering the immune system's ability to fight the fungal infection histoplasmosis. This drug use increases susceptibility to opportunistic pathogens and worsens disease outcomes.

Area of Science:

  • Immunology
  • Infectious Diseases
  • Pharmacology

Background:

  • Methamphetamine abuse is a significant public health issue.
  • Chronic use increases HIV risk and potentially other infections.
  • Histoplasma capsulatum causes opportunistic infections, especially in immunocompromised individuals.

Purpose of the Study:

  • To investigate the impact of methamphetamine on the host immune response to Histoplasma capsulatum.
  • To elucidate the mechanisms by which methamphetamine affects macrophage function and immune cells.

Main Methods:

  • Primary macrophages were used to assess phagocytosis and yeast killing.
  • A murine model of histoplasmosis was employed to evaluate host response.
  • Analysis included cytokine profiles, macrophage receptor function, T cell proliferation, and antibody production.

Main Results:

  • Methamphetamine impaired macrophage phagocytosis and killing of H. capsulatum by altering phagosome pH.
  • Mice treated with methamphetamine exhibited increased fungal burden, pulmonary inflammation, and reduced survival.
  • Methamphetamine suppressed T cell proliferation and altered antibody production, indicating adaptive immunity impairment.

Conclusions:

  • Methamphetamine compromises macrophage function and abrogates host defense against H. capsulatum.
  • Drug-induced immunosuppression exacerbates fungal pathogenesis and increases mortality.
  • Methamphetamine alters critical immune pathways, increasing susceptibility to opportunistic fungal infections.

Related Concept Videos

Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Amebiasis01:28

Amebiasis

Entamoeba histolytica, a protozoan parasite, is responsible for intestinal and extraintestinal amebiasis. Though a significant proportion of infections remain asymptomatic, approximately 50 million individuals annually are estimated to present with clinical disease, resulting in up to 100,000 deaths globally. The disease burden is disproportionately high in regions with lower socioeconomic status, such as parts of India, Africa, Mexico, and Latin America.Etiology and TransmissionThe infective...
Antiprotozoal Agents01:21

Antiprotozoal Agents

Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Toxoplasmosis01:28

Toxoplasmosis

Toxoplasmosis, a zoonotic disease caused by the protozoan Toxoplasma gondii, poses significant public health challenges globally due to its high seroprevalence and varied clinical manifestations. As an obligate intracellular parasite, T. gondii can infect all warm-blooded vertebrates, but felids are its only definitive hosts, shedding unsporulated oocysts into the environment. Humans typically acquire the infection through ingestion of tissue cysts in undercooked meat or oocysts from...